Center-Authored Papers

Filters: Author is Culakova, Eva  [Clear All Filters]
Journal Article
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.  2010.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2914-24. Abstract
Halpern AB, Culakova E, Walter RB, Lyman GH.  2016.  Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit.. JAMA oncology. Abstract
Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.  2008.  Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.. Archives of internal medicine. 168(21):2377-81. Abstract
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW.  2008.  Development and validation of a predictive model for chemotherapy-associated thrombosis.. Blood. 111(10):4902-7. Abstract
Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH.  2009.  Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.. Cancer. 115(22):5319-28. Abstract
Shayne M, Culakova E, Poniewierski MS, Wolff D, Dale DC, Crawford J, Lyman GH.  2007.  Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.. Cancer. 110(7):1611-20. Abstract
Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.  2008.  Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(2):172-9. Abstract
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.  2007.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.. Cancer. 110(10):2339-46. Abstract
Schwenkglenks M, Pettengell R, Szucs TD, Culakova E, Lyman GH.  2010.  Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.. Journal of hematology & oncology. 3:27. Abstract
Culakova E, Poniewierski MS, Wolff DA, Dale DC, Crawford J, Lyman GH.  2015.  The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study.. SpringerPlus. 4:396. Abstract
Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH.  2010.  Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.. Thrombosis research. 126(2):113-8. Abstract
Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH.  2014.  Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.. Cancer medicine. 3(2):434-44. Abstract
Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC.  2011.  Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.. Cancer. 117(9):1917-27. Abstract
Wolff D, Culakova E, Poniewierski MS, Lyman GH, Dale DC, Crawford J.  2005.  Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.. The journal of supportive oncology. 3(6 Suppl 4):24-5.
Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH.  2006.  Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.. Breast cancer research and treatment. 100(3):255-62. Abstract
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Khorana AA, Francis CW, Culakova E, Lyman GH.  2005.  Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.. Cancer. 104(12):2822-9. Abstract
Shayne M, Culakova E, Poniewierski MS, Dale DC, Crawford J, Wogu AF, Lyman GH.  2013.  Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies.. Journal of geriatric oncology. 4(4):310-8. Abstract
Lyman GH, Poniewierski MS, Culakova E.  2016.  Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.. Expert opinion on drug safety. Abstract
Griggs JJ, Culakova E, Sorbero MES, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18):2522-7. Abstract
Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P et al..  2008.  Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.. International journal of radiation oncology, biology, physics. 72(1):24-33. Abstract
Cosler LE, Eldar-Lissai A, Culakova E, Kuderer NM, Dale D, Crawford J, Lyman GH.  2007.  Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.. PharmacoEconomics. 25(4):343-51. Abstract
Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.  2006.  Thromboembolism in hospitalized neutropenic cancer patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(3):484-90. Abstract
Lyman GH, Culakova E, Griggs J.  2004.  Use of antibiotics and risk of cancer.. JAMA : the journal of the American Medical Association. 291(22):2700;authorreply2700.